Shanghai Junshi Biosciences Co., Ltd. (HKG:1877)

Hong Kong flag Hong Kong · Delayed Price · Currency is HKD
21.42
+0.38 (1.81%)
Feb 13, 2026, 4:08 PM HKT
Market Cap35.48B +48.6%
Revenue (ttm)2.71B +38.9%
Net Income-1.04B
EPS-1.05
Shares Out1.03B
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume1,469,796
Average Volume4,169,314
Open21.00
Previous Close21.04
Day's Range20.90 - 21.42
52-Week Range11.64 - 38.64
Beta0.79
RSI40.25
Earnings DateMar 14, 2026

About HKG:1877

Shanghai Junshi Biosciences Co., Ltd., a biopharmaceutical company, engages in the discovery, development, and commercialization of various drugs in the therapeutic areas of malignant tumors, neurological, autoimmune, chronic metabolic, nervous system, and infectious diseases in the People's Republic of China. The company was founded in 2012 and is headquartered in Shanghai, People's Republic of China. [Read more]

Industry Biotechnology
Sector Healthcare
Founded 2012
Employees 2,670
Stock Exchange Hong Kong Stock Exchange
Ticker Symbol 1877
Full Company Profile

Financial Performance

In 2024, HKG:1877's revenue was 1.95 billion, an increase of 29.67% compared to the previous year's 1.50 billion. Losses were -1.28 billion, -43.90% less than in 2023.

Financial numbers in CNY Financial Statements